[HTML][HTML] The anatomy of pain and suffering in the brain and its clinical implications
Pain is an unpleasant sensory and emotional experience associated with actual or potential
tissue damage. Chronic pain, with a prevalence of 20–30% is the major cause of human …
tissue damage. Chronic pain, with a prevalence of 20–30% is the major cause of human …
Postoperative cognitive dysfunction: minding the gaps in our knowledge of a common postoperative complication in the elderly
Ever since Bedford's 1 seminal Lancet case series in 1955, we have known that
perioperative care is sometimes followed by significant cognitive dysfunction. Although the …
perioperative care is sometimes followed by significant cognitive dysfunction. Although the …
Co-morbidity of PTSD and immune system dysfunction: opportunities for treatment
GN Neigh, FF Ali - Current opinion in pharmacology, 2016 - Elsevier
Highlights•PTSD co-occurs with somatic diseases.•PTSD is commonly associated with
neuroendocrine and immune dysfunction.•Targeting neuroendocrine and immune …
neuroendocrine and immune dysfunction.•Targeting neuroendocrine and immune …
[HTML][HTML] Ketamine for the treatment of refractory status epilepticus
Y Fang, X Wang - Seizure, 2015 - Elsevier
Status epilepticus (SE) is an acute and severe illness of the central nervous system, and
prolonged SE can lead to brain damage and even death. Ketamine is a noncompetitive …
prolonged SE can lead to brain damage and even death. Ketamine is a noncompetitive …
[HTML][HTML] miR-98-5p plays a critical role in depression and antidepressant effect of ketamine
C Huang, Y Wang, Z Wu, J Xu, L Zhou, D Wang… - Translational …, 2021 - nature.com
Ketamine has been demonstrated to be a rapid-onset and long-lasting antidepressant, but
its underlying molecular mechanisms remain unclear. Recent studies have emerged …
its underlying molecular mechanisms remain unclear. Recent studies have emerged …
Repurposing of drugs–the ketamine story
J Das - Journal of Medicinal Chemistry, 2020 - ACS Publications
An intranasal formulation of esketamine, the S enantiomer of ketamine, in conjunction with
an oral antidepressant, has been approved by the FDA for treating treatment-resistant major …
an oral antidepressant, has been approved by the FDA for treating treatment-resistant major …
Ketamine: an update on cellular and subcellular mechanisms with implications for clinical practice
GJ Iacobucci, O Visnjevac, L Pourafkari… - Pain …, 2017 - search.proquest.com
BACKGROUND: Ketamine is one of the oldest hypnotic agents used to provide an
anesthetic agent with analgesic properties and minimal suppressive effects on respiration …
anesthetic agent with analgesic properties and minimal suppressive effects on respiration …
Drug pharmacokinetics determined by real‐time analysis of mouse breath
X Li, P Martinez‐Lozano Sinues… - Angewandte Chemie …, 2015 - Wiley Online Library
Noninvasive, real‐time pharmacokinetic (PK) monitoring of ketamine, propofol, and valproic
acid, and their metabolites was achieved in mice, using secondary electrospray ionization …
acid, and their metabolites was achieved in mice, using secondary electrospray ionization …
Drug repurposing may generate novel approaches to treating depression
ME Ebada - Journal of Pharmacy and Pharmacology, 2017 - academic.oup.com
Objectives The breakthrough advancements in scientific medical research have greatly
improved our understanding of the pathogenesis of depression, encouraging drug …
improved our understanding of the pathogenesis of depression, encouraging drug …
Ketamine‐an update on its clinical uses and abuses
J Xu, H Lei - CNS neuroscience & therapeutics, 2014 - Wiley Online Library
This review highlights the recent clinical research that supports the therapeutic utility of
ketamine as a multifaceted drug. After long‐term use as a dissociative anesthetic, it has re …
ketamine as a multifaceted drug. After long‐term use as a dissociative anesthetic, it has re …